Published in Obesity and Diabetes Week, March 27th, 2006
The company plans to use the proceeds to support ongoing clinical trials, expand the product portfolio, and launch its first product commercially. In addition to Chicago Growth Partners, the company's existing investors, MPM Capital, Advanced Technology Ventures (ATV), and Foundation Medical Partners, participated with increased investments over previous rounds as did a new investor, Oakwood Medical Investors.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.